ownitsafely
Back to recalls

FDARecalled Oct 7, 2026 · #D-0010-2027

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

Hazard

Class II — temporary health risk

Be the first to hear about future recalls.

Add the things you own to a watchlist. We’ll alert you the moment one matches.

Get started, free

Description

Failed Dissolution Specifications: below specification Classification: Class II Distribution: Nationwide in the US.

Product details

Product
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Type
Drugs
Manufacturer
Ajanta Pharma USA Inc
Model numbers
DJ25134
UPCs
—